Kala Pharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for KALA, updated each market day.
KALA AI Sentiment
AI predicts Kala Pharmaceuticals, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Kala Pharmaceuticals, Inc. Common Stock
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Sector
Exchange
Market Cap
$143,141,703
Cap Tier
Employees
6
Headquarters
ARLINGTON, MA
Listed Since
July 20, 2017
Website
KALA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
KALA Volatility
Kala Pharmaceuticals, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
